A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord

被引:49
作者
Malaspina, A
Kaushik, N
de Belleroche, J
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Neuromuscular Dis, Div Neurosci & Psychol Med, London W6 8RF, England
[2] Univ Pavia, Fdn Casimiro Mondino, I-27100 Pavia, Italy
关键词
14-3-3; mRNA; amyotrophic lateral sclerosis; spinal cord; mRNA expression;
D O I
10.1046/j.1471-4159.2000.0752511.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently isolated a 2.2-kb cDNA clone (1C5) from a human spinal cord cDNA library with partial identity to the 14-3-3 protein mRNA encoding the a protein (YWHAQ). 14-3-3 protein transcripts are highly expressed in large projection neurones of the hippocampus, cerebellum, and spinal cord and have been found to be significantly up-regulated in rat motor neurones following hypoglossal nerve axotomy. In this study we investigated whether the 1C5 transcript (YWHAQ) isolated from spinal cord was involved in amyotrophic lateral sclerosis (ALS). We found a significant up-regulation of 1C5 (YWHAQ) in lumbar spinal cord from patients with sporadic ALS compared with controls, with the highest levels of expression being found in individuals with predominant lower motor neurone involvement. A 6-bp tandem repeat in the 5'-untranslated region of the gene was found to be polymorphic, but no significant association with disease was found following genomic analysis of this region. The localisation of 1C5 (YWHAQ) to chromosome 2 was determined and coincides with that reported for clone HS1 (EMBL accession no. X57347), These results show the marked up-regulation of the 14-3-3 isoform (YWHAQ) in ALS spinal cord and indicate the involvement of a potential 14-3-3-mediated survival pathway in the pathogenesis of ALS.
引用
收藏
页码:2511 / 2520
页数:10
相关论文
共 42 条
[1]  
AITKEN A, 1990, NATURE, V344, P594
[2]   Acute systematic and variable postural adaptations induced by an orthopaedic shoe lift in control subjects [J].
Beaudoin, L ;
Zabjek, KF ;
Leroux, MA ;
Coillard, C ;
Rivard, CH .
EUROPEAN SPINE JOURNAL, 1999, 8 (01) :40-45
[3]   PURIFICATION, PROPERTIES, AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN-BRAIN 14-3-3 PROTEIN [J].
BOSTON, PF ;
JACKSON, P ;
KYNOCH, PAM ;
THOMPSON, RJ .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) :1466-1474
[4]  
Brandfonbrener AG, 1999, MED PROBL PERFORM AR, V14, P3
[5]   Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis [J].
Cudkowicz, ME ;
McKennaYasek, D ;
Sapp, PE ;
Chin, W ;
Geller, B ;
Hayden, DL ;
Schoenfeld, DA ;
Hosler, BA ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1997, 41 (02) :210-221
[6]   Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease amyotrophic lateral sclerosis [J].
de Belleroche, J ;
Orrell, RW ;
Virgo, L ;
Habgood, J ;
Gardiner, IM ;
Malaspina, A ;
Kaushik, N ;
Mitchell, J ;
Greenwood, J .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (03) :476-480
[7]  
deBelleroche J, 1996, J NEUROPATH EXP NEUR, V55, P747
[8]   REGIONAL DISTRIBUTION OF CHOLECYSTOKININ MESSENGER-RNA IN RAT-BRAIN DURING DEVELOPMENT - QUANTITATION AND CORRELATION WITH CHOLECYSTOKININ IMMUNOREACTIVITY [J].
DEBELLEROCHE, J ;
BANDOPADHYAY, R ;
KING, A ;
MALCOLM, ADB ;
OBRIEN, K ;
PREMI, BP ;
RASHID, A .
NEUROPEPTIDES, 1990, 15 (04) :201-212
[9]   14-3-3 proteins interact with specific MEK kinases [J].
Fanger, GR ;
Widmann, C ;
Porter, AC ;
Sather, S ;
Johnson, GL ;
Vaillancourt, RR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3476-3483
[10]   IDENTIFICATION OF 2 HUMAN BETA-TUBULIN ISOTYPES [J].
HALL, JL ;
DUDLEY, L ;
DOBNER, PR ;
LEWIS, SA ;
COWAN, NJ .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (05) :854-862